Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 298, Issue 5, 2010, Pages

  Blomme, Bram ^a   Van Steenkiste, Christophe ^a   Vanhuysse, Jacques ^a   Colle, Isabelle ^a   Callewaert, Nico ^b   Van Vlierberghe, Hans ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

1 6 fucose; Biomarker; DSA FACE; Glycomics; Hyperbilirubinemia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; C REACTIVE PROTEIN; CARBON TETRACHLORIDE; FUCOSE; GAMMA GLUTAMYLTRANSFERASE; GLYCAN;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FUCOSYLATION; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SPECTROPHOTOMETRY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BILIRUBIN; CARBOHYDRATE SEQUENCE; CARBON TETRACHLORIDE POISONING; CARCINOMA, HEPATOCELLULAR; COMMON BILE DUCT; FEMALE; FUCOSE; GALACTOSE; GLYCOSYLATION; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; HYPERTENSION, PORTAL; LIGATION; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; POLYSACCHARIDES;

EID: 77951463025     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00414.2009     Document Type: Article

References (22)

1. Al Knawy B, Shiffman M. Percutaneous liver biopsy in clinical practice. Liver Int 27: 1166-1173, 2007.
2. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24: 289-293, 1996.
3. Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 10: 429-434, 2004.
4. Chen C, Schmilovitz-Weiss H, Liu XE, Pappo O, Halpern M, Sulkes J, Braun M, Cohen M, Barak N, Tur-Kaspa R, Vanhooren V, Van Vlierberghe H, Libert C, Contreras R, Ben-Ari Z. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis. J Proteome Res 8: 463-470, 2009.
5. Chen G, Guan M, Su B, Lu Y. mRNA expression of three glycosyltransferases in human hepatoma tissues. Clin Chim Acta 313: 77-80, 2001.
6. Comunale MA, Lowman M, Long RE, Krakover J, Philip R, Seeholzer S, Evans AA, Hann HW, Block TM, Mehta AS. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res 5: 308-315, 2006.
7. Fernandez M, Vizzutti F, Garcia-Pagan J, Rodes J, Bosch J. Anti-VEGF Receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology 126: 886-894, 2004.
8. Geerts AM, Vanheule E, Praet M, Van Vlierberghe H, De Vos M, Colle I. Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation. Int J Exp Pathol 89: 251-263, 2008.
9. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 36: 437-441, 1995.
10. Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. Gut 45: S1-S11, 1999.
11. Janakat S, Al-Merie H. Optimization of the dose and route of injection, and characterization of the time course of carbo tetrachloride-induced hepatotoxicity in the rat. J Pharmacol Toxicol Methods 48: 41-44, 2002.
12. Koike C, Uddin M, Wildman DE, Gray EA, Trucco M, Starzl TE, Goodman M. Functionally important glycosyltransferase gain and loss during catarrhine primate emergence. Proc Natl Acad Sci USA 104: 559-564, 2007.
13. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in rat. Br J Exp Pathol 65: 305-311, 1984.
14. Laroy W, Contreras R, Callewaert N. Glycome mapping on DNA sequencing equipment. Nat Protoc 1: 397-405, 2006.
15. Liu XE, Desmyter L, Gao CF, Laroy W, Dewaele S, Vanhooren V, Wang L, Zhuang H, Callewaert N, Libert C, Contreras R, Chen C. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology 46: 1426-1435, 2007.
16. Nakagawa T, Uozumi N, Nakano M, Mizuno-Horikawa Y, Okuyama N, Taguchi T, Gu J, Kondo A, Taniguchi N, Miyoshi E. Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts. J Biol Chem 281: 29797-29806, 2006.
17. Noda K, Miyoshi E, Uozumi N, Yanagidani S, Ikeda Y, Gao C, Suzuki K, Yoshihara H, Yoshikawa K, Kawano K, Hayashi N, Hori M, Taniguchi N. Gene expression of alpha 1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein. Hepatology 28: 944-952, 1998.
18. Ohno M, Nishikawa A, Koketsu M, Taga H, Endo Y, Hada T, Higashino K, Taniguchi N. Enzymatic basis of sugar structures of alpha-fetoprotein in hepatoma and hepatoblastoma cell lines: correlation with activities of alpha 1-6 fucosyltransferase and N-acetylglucosaminyltransferases III and V. Int J Cancer 51: 315-317, 1992.
19. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy: a multicenter retrospective study on 68,276 biopsies. J Hepatol 2: 165-173, 1986.
20. Van Beneden K, Coppieters K, Laroy W, De Keyser F, Hoffman IE, Van den Bosch F, Vander Cruyssen B, Drennan M, Jacques P, Rottiers P, Verbruggen G, Contreras R, Callewaert N, Elewaut D. Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis. Ann Rheum Dis 68: 1360-1365, 2009.
21. Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics 8: 986-994, 2009.
22. Wallace K, Burt AD, Wright MC. Liver fibrosis. Biochem J 411: 1-18, 2008.